AbCellera Biologics Inc. ABCL Canada — Total Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s canada — total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s canada — total revenue?
- AbCellera Biologics Inc. (ABCL) reported canada — total revenue of $16M in Q4 2025.
- How has AbCellera Biologics Inc.'s canada — total revenue changed year-over-year?
- AbCellera Biologics Inc.'s canada — total revenue increased by 144.3% year-over-year, from $6.55M to $16M.
- What is the long-term trend for AbCellera Biologics Inc.'s canada — total revenue?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s canada — total revenue has grown at a -34.8% compound annual growth rate (CAGR), from $353.4M to $64M.
- What does canada — total revenue mean?
- Measures the total gross income generated by the company's operations within the Canadian market. It serves as the primary indicator of the segment's market penetration, commercial success, and contribution to the overall corporate top-line performance.